OPRX - OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript
2025-03-12 11:04:09 ET
OptimizeRx Corporation (OPRX)
Q4 2024 Results Conference Call
March 12, 2025 08:30 AM ET
Company Participants
Steve Silvestro - President
Edward Stelmakh - Chief Financial Officer and Chief Operational Officer
Andrew D'Silva - Senior Vice President of Corporate Finance
Conference Call Participants
Jared Haase - William Blair
Anderson Schock - B. Riley
Constantine Davides - Citizens JMP
Richard Baldry - ROTH Capital
David Grossman - Stifel Financial
Eric Martinuzzi - Lake Street
Jeff Garro - Stephens, Inc
Presentation
Operator
Good morning, everyone, and thank you for joining OptimizeRx's Fourth Quarter and Full Year Fiscal 2024 Earnings Conference Call. With us today is Chief Executive Officer, Steve Silvestro. He is joined by Chief Financial Officer, Ed Stelmakh; Chief Legal Officer, Marion Odense-Ford; and Senior Vice President of Corporate Finance, Andrew D'Silva.
At the conclusion of today's call, I will provide some important cautions regarding the forward-looking statements made by management during today's call. The company will also be discussing certain non-GAAP financial measures which it believes are useful in evaluating the company's operating results. A reconciliation of such non-GAAP financial measures is included in the earnings release the company issued this morning as well as in the Investor Relations section of the company's website.
I would like to remind everyone that today's call is being recorded and will be made available for replay as an audio recording of this conference call and will also be provided on the Investor Relations section of the company's website.
Now I would like to turn the call over to OptimizeRx CEO, Steve Silvestro. Sir, please go ahead.
Steve Silvestro
Thank you, operator, and good morning, everyone. Thank you for joining today's fourth quarter and fiscal 2024 earnings call. As many of you know, this is my third day as OptimizeRx's new CEO. I'm honored to have the opportunity to lead the next phase of OptimizeRx's growth and transformation. Now more than ever, we will be laser-focused on operational excellence while ensuring we delight our customers and forge stronger relationships with valued business partners....
OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript